z-logo
open-access-imgOpen Access
PRE-EMPTIVE PAIN CONTROL
Author(s) -
Muhammad Nasir,
Khawar Latif,
Malik Jamil Ahmad
Publication year - 2007
Publication title -
the professional medical journal/the professional medical journal
Language(s) - English
Resource type - Journals
eISSN - 2071-7733
pISSN - 1024-8919
DOI - 10.29309/tpmj/2007.14.04.4812
Subject(s) - medicine , ketorolac , analgesic , diclofenac sodium , anesthesia , bupivacaine , visual analogue scale , general anaesthesia , diclofenac , local anaesthetic , local anesthetic , surgery , pharmacology
Opioid related side effects have encouraged the use of analgesic drugs that are devoidof these problems. Objective:- This study was done to compare the analgesic efficacy of Ketorolac and diclofenacin 60 adult patients of age group ranging between 30 to 45 years of age body wt 50-60kg belonging to ASA I and IIgrade. Material and Methods: Patients were scheduled for elective gynecological procedure (laparoscopic tuballigation) under general anaesthesia. They were divided into two equal groups using non-probability conveniencesampling technique. Each group comprised of 30 patients. Group A received Ketorolac 10 mg I/V with local infiltrationof 0.5% Bupivacaine and group B received IM Diclofenac sodium 75 mg after local infiltration 0.5% bupivacaine asin Group A ½ hourly before surgery. Post operatively patients were observed after 30 minutes in the recovery roomfor pain relief for two hours. Mean pain scores were noted in the recovery area using visual analog scale with need forsupplementary analgesic after awakening from general anaesthesia. Vital signs were monitored. Result: Results wereanalyzed by using SPSS-8 package by applying Student Test and chi Square Test. There was statistically significantdifference between two groups regarding their mean pain score. Conclusion: The patients who received KetorolacI/V (Group A) had longer pain free time interval and request for first analgesic supplement was made after 90 minutescompared to a shorter interval of 60 minutes in Group-B, who received intramuscular diclofenac sodium.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here